시장보고서
상품코드
1473924

세계의 당뇨병 치료 기기 및 약제 시장 규모, 점유율, 성장 분석 : 제품별, 최종 용도별 - 산업 예측(2024-2031년)

Global Diabetes Care Devices and Drugs Market Size, Share, Growth Analysis, By Product(Blood glucose monitoring devices and Insulin delivery devices), By End use(Hospitals, Ambulatory surgery centres) - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 219 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 당뇨병 치료 기기·약제 시장 규모는 2022년에 335억 3,000만 달러에 달하며, 2023년 361억 8,000만 달러에서 2031년까지는 664억 7,000만 달러로 성장하며, 예측 기간(2024-2031년)의 CAGR은 7.9%로 성장할 전망입니다.

췌장에서 분비되는 인슐린이라는 호르몬은 혈당을 조절하는 역할을 합니다. 체내에서 혈당을 조절하기에 충분한 인슐린이 만들어지지 않으면 당뇨병이 발생합니다. 혈당 수치는 당뇨병 치료 기기로 모니터링합니다. 지속적 혈당 모니터는 당뇨병 환자가 하루 종일 혈당 수치를 추적하고 모니터링하는 데 사용하는 장비 중 일부입니다. 당뇨병을 앓고 있는 사람들은 이 웨어러블 기기를 통해 보다 쉽게 혈당 관리를 할 수 있으며, 21세기 세계 건강이 직면한 가장 큰 문제 중 하나는 당뇨병입니다. 이 질병에 드는 사람은 해마다 증가하고 있으며, 심각한 결과를 초래할 수 있습니다. 국제당뇨병연맹(IDF)의 추산에 따르면 미국에서는 20세에서 79세 사이의 성인 5억 3,700만 명이 당뇨병을 앓고 있습니다.

목차

주요 요약

  • 시장 개요
  • Wheel of Fortune

조사 방법

  • 정보 조달
  • 2차·1차 정보원
  • 시장 규모 추정
  • 시장의 전제조건과 제한

모시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인
    • 기회
    • 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장의 에코시스템
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공요인
  • 경쟁의 정도

시장 역학과 전망

  • 시장 역학
    • 촉진요인
    • 기회
    • 억제요인
    • 과제
  • 규제 상황
  • Porter의 산업 분석
  • 향후 혼란에 관한 특별 인사이트

세계의 당뇨병 치료 기기·약제 시장 : 제품별

  • 시장 개요
  • 혈당 모니터링 기기·인슐린 투여 기기

세계의 당뇨병 치료 기기·약제 시장 : 최종 용도별

  • 시장 개요
  • 병원
  • 외래 수술 센터
  • 진단 센터
  • 홈케어

세계의 당뇨병 치료 기기·약제 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카(MEA)
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2023년)

주요 기업 개요

  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Dexcom, Inc.
  • Insulet Corporation
  • Ypsomed AG
  • Ascensia Diabetes Care Holdings AG
  • Tandem Diabetes Care, Inc.
  • Senseonics Holdings, Inc.
  • B. Braun Melsungen AG
  • Terumo Corporation
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Novartis AG
KSA 24.05.16

Global Diabetes Care Devices and Drugs Market size was valued at USD 33.53 billion in 2022 and is poised to grow from USD 36.18 billion in 2023 to USD 66.47 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

The hormone insulin produced by the pancreas regulates blood glucose levels. When the body does not create enough insulin to regulate blood glucose levels, diabetes develops. Blood glucose levels are monitored by means of diabetes care devices. A continuous glucose monitor is a piece of equipment used by diabetic patients to track and keep an eye on their blood sugar levels all day long. Those who have diabetes may find this wearable device helpful as it can facilitate easier glucose management. One of the biggest issues facing global health in the twenty-first century is diabetes. An increasing number of people are affected by the illness each year, which can have serious consequences. The International Diabetes Federation (IDF) estimates that 537 million adults in the United States between the ages of 20 and 79 have diabetes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Care Devices and Drugs Marketand to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Care Devices and Drugs Market Segmental Analysis

Global diabetes care devices and drugs market is segmented based on product, end use and region. Based on product, global diabetes care devices and drugs market is sub-segmented into blood glucose monitoring devices and insulin delivery devices. Based on end use, diabetes care devices and drugs market is sub-segmented into hospitals, ambulatory surgery centres, diagnostic centres, and home care. Based on region, global diabetes care devices and drugs market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and MEA.

Drivers of the Global Diabetes Care Devices and Drugs Market

One of the main factors propelling the growth of the global market for diabetes care devices and pharmaceuticals is the launch of new products in the form of treatment devices and monitoring systems. For instance, Universidade de Lisboa researchers in Portugal revealed in April 2020 that chitosan coating of insulin-loaded nanoparticles could improve insulin oral delivery. Growing R&D expenditures and research partnerships can open up more avenues for the market's continued expansion.

Restraints in the Global Diabetes Care Devices and Drugs Market

The global market for diabetes care devices and medications may not grow as quickly as it could due to harsh limitations, rising obesity rates, and a lack of reimbursement in some countries. The global market for diabetic devices and medications is predicted to grow slowly because to a lack of knowledge about diabetes diagnosis and treatment, particularly in developing nations.

Market Trends of the Global Diabetes Care Devices and Drugs Market

The global market trend is expected to be good due to the coronavirus pandemic. Due to the increased risk of infection from the coronavirus for those with diabetes, there has been a rise in demand in recent years for diabetes monitoring tools. Devices were essential for illness management since people with diabetes wanted to minimize hospital stays and visits.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Diabetes Care Devices and Drugs Market by Product

  • Market Overview
  • Blood glucose monitoring devices and Insulin delivery devices

Global Diabetes Care Devices and Drugs Market by End use

  • Market Overview
  • Hospitals
  • Ambulatory surgery centres
  • Diagnostic centres
  • Home care

Global Diabetes Care Devices and Drugs Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Novo Nordisk A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Services, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dexcom, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Insulet Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ascensia Diabetes Care Holdings AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tandem Diabetes Care, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Senseonics Holdings, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim International GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제